All stock lists
Pacific Biosciences Of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
Healthcare · Medical Devices
2.27+0.16 (+7.43%)
Insider Score
––Not scored
PACB Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
PACB Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 39.01 M | 37.18 M | 44.65 M | 38.44 M | 39.77 M | 37.15 M |
| Revenue Growth (YoY) | -1.91 % | 0.07 % | 13.82 % | -3.82 % | 10.42 % | -4.27 % |
| Cost of Revenue | 26.37 M | 24.34 M | 27.90 M | 23.37 M | 25.08 M | 38.52 M |
| Gross Profit | 12.64 M | 12.84 M | 16.75 M | 15.07 M | 14.68 M | -1.37 M |
| SG&A Expense | 33.39 M | 31.15 M | 34.05 M | 31.10 M | 36.17 M | 40.17 M |
| R&D Expense | 23.02 M | 19.61 M | 22.88 M | 22.85 M | 22.53 M | 29.05 M |
| Operating Expenses | 57.25 M | 50.76 M | 57.95 M | 53.88 M | 59.54 M | 427.56 M |
| Operating Income | -44.61 M | -37.92 M | -41.20 M | -38.81 M | -44.85 M | -428.93 M |
| Pretax Income | -44.68 M | -8.09 M | -40.17 M | -37.62 M | -41.90 M | -426.38 M |
| Tax Provision | 58.00 K | 184.00 K | 202.00 K | 383.00 K | 35.00 K | -302.00 K |
| Net Income | -44.74 M | -8.28 M | -40.37 M | -38.00 M | -41.93 M | -426.07 M |
| EPS (Basic) | -0.14 | -0.03 | -0.13 | -0.13 | -0.14 | -1.44 |
| EPS (Diluted) | -0.14 | -0.03 | -0.13 | -0.13 | -0.14 | -1.44 |
| Shares Outstanding | 310.65 M | 305.82 M | 301.91 M | 300.84 M | 300.16 M | 296.86 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.